Focus Stocks
Oracle Near to the 50 and 200 Day Moving Averages
Published on Thursday, 09 September 2010 04:36 Written by Christian Paolinetti
New York, September 9th (TradersHuddle.com) - Shares of Oracle Corporation (NASDAQ:ORCL) closed the trading session at $24.14 near its 50 day and 200 day moving averages currently set at $23.2899 and $23.925 respectively. Oracle's price action is above these important levels, which could translate into a trading opportunity.
Oracle Corporation (NASDAQ:ORCL) supplies software for enterprise information management. The Company offers databases and relational servers, application development, and enterprise business applications.
Although the price action is above important moving averages, it's important to highlight that the 50 day moving average is currently below the 200 day moving average resulting in not a prime setup where buying the dip will present a good trading opportunity.
Looking at peaks and troughs horizontal support and resistance levels, we can see current calculated support at $21.66 and calculated resistance at $24.69. These levels should also be evaluated by traders when planning their trades, as they provide an insight into the latest price action.
If traders want to establish a position on Oracle, should evaluate their trade, as it will certainly be better to wait, given that the stock is technically broken with the 50 day moving average trading below the 200 day moving average. Traders can also look at the current range defined by the peaks and troughs see where the current price action of stock is and establish a short trade versus those levels.
Related Articles
- Oracle Close to 50 Day Moving Average
- Key Level for Oracle
- Up/Downgrades ( RBCN, MCD, SBUX, RF, RBS, EAT, TEX, ATK, ORCL, TCB )
- ETF Of The Day: XLK; Perfect Timing
- Oracle Corporation to Ring the NASDAQ Stock Market Opening Bell
- Oracle near Key Resistance Area
- Up/Downgrades (AKAM, BRCM, CMCSA, EE, FCS, FOSL, HIG, MET, MR, RL, ANF, AFL, COST, MRK, ORCL, PFG, SFG, TJX, XL)
- Oracle near Resistance
- Playing the Momentum Building in Oracle
- Stocks Jump for the Week on Economic Data (AAPL, BAC, FSLR, IBM, MU, ORCL, PHM, S, TRIP, VMW, XLF)
Related Partner Headlines
- Oracle Issues Statement Regarding Litigation with HP - Benzinga
- From Earlier: Court Rejects Oracle's Attempt to Use Fraud Claim to Undo Contract With HP - Benzinga
- Ambow Announces Partnership with Oracle to Provide the Workforce Development Program - Benzinga
- Oracle Stock To Go Ex-dividend Monday (ORCL) - TheStreet.com
- Market Morning: Europe Stages Rebound - TheStreet.com
- 'Fast Money' Recap: How to Play Tech Now - TheStreet.com
- Oracle Takes Its Eyes off the Ball - TheStreet.com
- Cramer: Oracle Lays an Egg - TheStreet.com
- Oracle Shares Tumble on Earnings Miss - TheStreet.com
- Oracle Corporation (ORCL): Today's Featured Computer Software & Services Winner - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Endologix Completes Enrollment in PEVAR Randomized Trial - Benzinga -
Canaccord Maintains Anadarko Petroleum at Buy, Raises PT from 1 to 7 - Benzinga -
Piper Jaffray Maintains Akamai Technologies at Neutral, Raises PT from to - Benzinga -
Canaccord Maintains Apple at Buy, Raises PT from 0 to 5 - Benzinga -
Jefferies Maintains Hold on Diamond Foods' Restatement - Benzinga -
Benzinga's Top Pre-Market Losers - Benzinga -
Jefferies & Company Maintains Mettler-Toledo International at Buy, Raises PT from 0 to 5 - Benzinga -
ChinaCast Education Terminates Stockholder Rights Plan and Appointment of New Board Committee Members - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
Sigma-Aldrich (NASDAQ: SIAL) Reports Diluted EPS of $0.89, a 17% Increase, and 5% Sales Growth for Q4 2011. Full Year 2011 Diluted EPS Increased 14%. 2012 Diluted EPS Expected to Increase to $3.90 to $4.05 -
Endologix Completes Enrollment in PEVAR Randomized Trial -
SRS Labs Partners With FMOD to Offer SRS 5.1 Surround Sound On Popular Gaming Platform -
Industrial Nanotech, Inc. Announces Successful Energy Saving Project with Textile Manufacturer Intem Triko -
David Colford Appointed as Geeknet Media's Executive Vice President of Global Sales and Operations -
Acetylon Announces $15 Million Strategic Equity Investment by Celgene Corporation -
Pacer International Reports Three Fold Increase in Income from Operations for the Fourth Quarter -
Alnylam Scientists Discover Novel Method for Monitoring RNAi Activity in Blood Samples










